NPI: 1174588933 · MILWAUKEE, WI 53202 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,202 | $626K |
| 2019 | 22,041 | $488K |
| 2020 | 16,621 | $582K |
| 2021 | 15,784 | $625K |
| 2022 | 9,530 | $554K |
| 2023 | 5,588 | $565K |
| 2024 | 5,949 | $472K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 45,006 | 3,354 | $3.88M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 25,861 | 1,287 | $18K |
| A4657 | Syringe, with or without needle, each | 2,494 | 1,611 | $12K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,012 | 221 | $2K |
| J1756 | Injection, iron sucrose, 1 mg | 5,426 | 1,192 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,924 | 1,206 | $847.41 |
| 90674 | 69 | 61 | $68.79 | |
| 83970 | 626 | 516 | $5.44 | |
| 82728 | 417 | 326 | $1.79 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 60 | 37 | $1.42 |
| 83550 | 410 | 326 | $1.15 | |
| 83540 | 410 | 326 | $0.86 | |
| 85041 | 946 | 781 | $0.40 | |
| 85048 | 942 | 778 | $0.34 | |
| G0008 | Administration of influenza virus vaccine | 112 | 91 | $0.00 |